Folyóiratcikkek tallózása szerző szerint "Ellison DW"

A találatok rendezése: Rendezés: Találatok:

  • DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies. 
    Schwalbe EC; Williamson D; Lindsey JC; Hamilton D; Ryan SL; Megahed H; Garami, Miklós; Hauser, Péter; Dembowska-Baginska B; Perek D; Northcott PA; Taylor MD; Taylor RE; Ellison DW; Bailey S; Clifford SC (2013)
    Molecular subclassification is rapidly informing the clinical management of medulloblastoma. However, the disease remains associated with poor outcomes and therapy-associated late effects, and the majority of patients are ...
  • Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma 
    Mynarek M; Pizer B; Dufour C; van Vuurden D; Garami, Miklós; Massimino M; Fangusaro J; Davidson T; Gil-da-Costa MJ; Sterba J; Benesch M; Gerber N; Juhnke BO; Kwiecien R; Pietsch T; Kool M; Clifford S; Ellison DW; Giangaspero F; Wesseling P; Gilles F; Gottardo N; Finlay JL; Rutkowski S; von Hoff K (2017)
  • Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas 
    Lassaletta A; Zapotocky M; Mistry M; Ramaswamy V; Honnorat M; Krishnatry R; Stucklin AG; Zhukova N; Arnoldo A; Ryall S; Ling C; McKeown, T; Loukides J; Cruz O; de Torres C; Ho CY; Packer RJ; Tatevossian R; Qaddoumi I; Harreld JH; Dalton JD; Mulcahy-Levy J; Foreman N; Karajannis MA; Wang SY; Snuderl M; Rao AN; Giannini C; Kieran M; Ligon KL; Garre ML; Nozza P; Mascelli S; Raso A; Mueller S; Nicolaides T; Silva K; Perbet R; Vasiljevic A; Conter CF; Frappaz D; Leary S; Crane C; Chan A; Ng HK; Shi ZF; Mao Y; Finch E; Eisenstat D; Wilson B; Carret AS; Hauser, Péter; Sumerauer D; Krskova L; Larouche V; Fleming A; Zelcer S; Jabado N; Rutka JT; Dirks P; Taylor MD; Chen SY; Bartels U; Huang A; Ellison DW; Bouffet E; Hawkins C; Tabori U (2017)
    Purpose BRAF V600E is a potentially highly targetable mutation detected in a subset of pediatric low-grade gliomas (PLGGs). Its biologic and clinical effect within this diverse group of tumors remains unknown. Patients and ...